AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
A large proportion of bladder cancer (BLCA) patients suffer from malignant progression to life-threatening muscle-invasive bladder cancer (MIBC). Inflammation is a critical event in cancer development, but little is known about the role of inflammation in BLCA. In this study, the expression of the i...
Saved in:
Main Authors: | Houhong Zhou (Author), Lei Zhang (Author), Weihan Luo (Author), Huaishan Hong (Author), Dongdong Tang (Author), Dewang Zhou (Author), Lingli Zhou (Author), Yuqing Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021) -
Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32
by: Kang Wu, et al.
Published: (2022) -
Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature
by: Oreoluwa Oladiran, et al.
Published: (2020) -
The Role of AIM2 Inflammasome in Knee Osteoarthritis
by: Yang J, et al.
Published: (2022) -
New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer
by: Jian-Zhou Cui, et al.
Published: (2024)